Hyperplasia of α-cells under defective glucagon signaling is not unique to rodent models, and a human case carrying a homozygous glucagon receptor mutation has been reported to show α-cell hyperplasia and islet cell tumor [22]. Here, GCGR is linked to pancreatic neuroendocrine tumor.